Patients treated with remdesivir had a significantly lower risk of mortality compared to those
not treated with remdesivir. Consistent with other studies, this large study of US clinical …

Background Remdesivir (RDV) improved clinical outcomes among hospitalized patients with
coronavirus disease 2019 (COVID-19) in randomized trials, but data from clinical practice …

This research evaluated the effect of inadequate blood pressure (BP) control on selected
cardiovascular (CV) disease outcomes and costs for American patients with hypertension. The …

Objective: Everolimus and axitinib are approved in the US to treat patients with advanced
renal cell carcinoma (RCC) after failure on sunitinib or sorafenib, and one prior systemic …

Background This study aimed to assess the efficacy of laparoscopic adjustable gastric banding
(LAGB) during a 6-year follow-up period. Methods A retrospective database analysis of …

Purpose The aim of this study was to compare the cost-effectiveness of cabozantinib with
the standard of care in England in adult patients with advanced renal cell carcinoma (aRCC), …

METHODS: We conducted a multinational pharmacoeconomic evaluation comparing the
immediate release form of a new class of serotonin norepinephrine reuptake inhibitor (SNRI), …

Background A recent indirect comparison study showed that sunitinib-refractory metastatic
renal cell carcinoma (mRCC) patients treated with everolimus are expected to have improved …

Background: The heptavalent pneumococcal polysaccharide-protein conjugate vaccine (PCV7)
confers protection against invasive pneumococcal disease (IPD) caused by serotypes …

The objective of this study was to evaluate the projected health benefits, costs, and cost-effectiveness
of pneumococcal conjugate vaccination for infants and children aged <5 years in …